Chandigarh UT Health Dept Marks Inquiry Into Sale Of Branded Drugs At Jan Aushadhi Store

Chandigarh : The UT health department on Friday marked an inquiry to check on the sale of branded medicines at the Jan Aushadhi store at the Government Multi-Specialty Hospital (GMSH), Sector 16, premises.

The development came after a patient, who visited the hospital’s orthopaedics department after getting severe knee pain, filed a written complaint with the UT health director, stating that the Jan Aushadhi store gave her branded medicines in place of the generic ones and also issued a wrong bill.

“The Jan Aushadhi store sold branded medicine to me at a cost of ₹235, but gave me a bill for a purchase amounting to ₹201. The authorities must check on the sale of the store,” the patient said in her complaint.

Addressing the same, UT health secretary Yashpal Garg said, “After receiving the complaint, the drug inspector has been asked to check on the working of the Jan Aushadhi store and to submit a report.”

After the inquiry was marked, the drug inspector conducted a surprise check on the store.

The health department, in a statement said, it was observed during the inspection that the kendra had stocked both Jan Aushadhi drugs and other branded medicines for sale.

“Eight types of branded drugs were seized. Certified copies of certain purchase and sale bills for branded and generic drugs were also taken on record, as evidence of sale of both types of drugs,” it further read.

The statement stated that the matter will be investigated further and that it would consult the Pharmaceuticals and Medical Devices Bureau of India regarding the guidelines related to the sale of drugs.

“If the violations are confirmed, appropriate actions will be taken against the Jan Aushadhi Kendra,” it added.

  • Related Posts

    • Pharma
    • July 26, 2024
    • 118 views
    US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

    Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

    • Pharma
    • July 26, 2024
    • 108 views
    Indian National Charged With Selling Counterfeit Cancer Drugs

    HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

    US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

    Indian National Charged With Selling Counterfeit Cancer Drugs

    Indian National Charged With Selling Counterfeit Cancer Drugs

    ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

    ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

    BIS Sanctioned 82 Medical Device Projects To Develop Standards

    BIS Sanctioned 82 Medical Device Projects To Develop Standards

    Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

    Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

    ‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

    ‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD